BFS
ACAD icon

Bare Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Bare Financial Services’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.2K Buy
245
+142
+138% +$3.12K ﹤0.01% 772
2026
Q1 		$2.29K Sell
103
-139
-57% -$3.32K ﹤0.01% 939
2025
Q4 		$6.46K Buy
242
+190
+365% +$4.54K ﹤0.01% 431
2025
Q3 		$1.11K Buy
52
+21
+68% +$497 ﹤0.01% 988
2025
Q2 		$669 Buy
+31
New +$576 ﹤0.01% 1038

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bare Financial Services's ACAD Position: Q2 2026 in Review

Bare Financial Services increased its Acadia Pharmaceuticals (ACAD) stake by 138% in Q2 2026, buying an estimated $3.12K and bringing the position to 245 shares worth $6.2K. The position accounts for ﹤0.01% of the portfolio, ranked #772.

Bare Financial Services first reported a position in ACAD in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.46K in Q4 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Bare Financial Services held 245 shares of Acadia Pharmaceuticals worth $6.2K as of Q2 2026.
  • Bare Financial Services bought 142 Acadia Pharmaceuticals shares in Q2 2026, an estimated $3.12K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #772 holding.
  • Bare Financial Services first reported a position in Acadia Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Bare Financial Services's Acadia Pharmaceuticals position peaked at $6.46K in Q4 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.